In today’s trade, shares of Infosys, Trent, Jio Financial, Hindustan Copper, Adani Energy among others will be in focus due to various news developments and fourth quarter results.
Infosys, Adani Energy, Tata Capital
Infosys is expected to report a relatively soft March quarter performance, with revenue growth moderating sequentially due to seasonality, even as full-year growth remains within guidance. According to an average of seven brokerages, the company is likely to post around 14% year-on-year growth in revenue and about 8% growth in profit for the quarter.Tata Communications
Tata Communications reported a sharp decline in its March quarter profit, with net profit falling 75% year-on-year (YoY) to Rs 259 crore, compared with Rs 1,040 crore in the same period last year. Revenue from operations, however, showed steady growth, rising 9% YoY to Rs 6,554 crore from Rs 5,990 crore earlier.
Jio Financial
Jio Financial Services and Allianz Group on Wednesday signed a binding agreement to form a 50:50 primary insurance joint venture to enter India’s general and health insurance segments, formalising a partnership first announced in July 2025.
Trent
Lifestyle retailer Trent reported a 26% growth in its consolidated net profit for the quarter ended March 31, 2026 at Rs 400 crore versus Rs 318 crore in the year ago period. The profit after tax (PAT) is attributable to the equity holders of the company. Revenue form operations in fourth quarter stood at Rs 5,028 crore, up 19% compared to Rs 4,216 crore in the corresponding quarter of the last financial year.
SBI Life
Life insurer SBI Life reported a marginal decline in its standalone profit to Rs 805 crore in the fourth quarter. The profit was down about 1% over the previous year quarter. Net premium income, meanwhile, increased 16% year-on-year (YoY) to Rs 27,684 crore.
Hindustan Copper
State-owned Hindustan Copper (HCL) has planned a capital expenditure of Rs 7,188.90 crore over the next five years for the expansion of its mines. The company is planning a capex of Rs 450 crore in the current year, followed by a spending of Rs 1,422 crore in 2027, and Rs 1,994 crore in 2028. Also, the company will spend Rs 2,227 crore in 2029 and Rs 1,095 crore in 2030.
Alkem Labs
Alkem Labs, India’s sixth largest drug maker by market share, is set to see a top management change. Vikas Gupta, who helmed the organization for close to three years as its CEO, is expected to move out in a few months, sources told ET.